PierianDX fetches $27 mln Series B

St. Louis-based PierianDx, a clinical genomics informatics company, has raised $27 million in Series B funding. ATW Partners and SJF Ventures led the round with participation from other investors that included Health Catalyst Capital, Inova Health Systems, RTI International and ARUP Laboratories.

Source: Press Release